Osaic Holdings
CGEM icon

Osaic Holdings’s Cullinan Oncology CGEM Stock Holding History

Osaic Holdings’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.46K Buy
384
+141
+58% +$1.81K ﹤0.01% 6644
2025
Q4 		$2.52K Buy
+243
New +$2.19K ﹤0.01% 7004
2025
Q3 		– Sell
-2,115
Closed -$15.9K – 7910
2025
Q2 		$15.9K Buy
+2,115
New +$17K ﹤0.01% 5872
2025
Q1 		– Sell
-110
Closed -$1.34K – 7479
2024
Q4 		$1.34K Buy
+110
New +$1.58K ﹤0.01% 6747
2024
Q3 		– Sell
-50
Closed -$872 – 7418
2024
Q2 		$872 Buy
+50
New +$1.06K ﹤0.01% 6853

Other funds holding CGEM

LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.58B AUM 138.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $369M AUM 78.25% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return